Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
ClinicalTrials.gov study NCT00657878. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT05044871. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
ClinicalTrials.gov study NCT02255097. IPD Sharing: YES. Countries: 0. Publications: 4.
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT05633199. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC
ClinicalTrials.gov study NCT04338620. IPD Sharing: NO. Countries: 1. Publications: 1.
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01196559. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT03081702. IPD Sharing: NO. Countries: 1. Publications: 1.
Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy
ClinicalTrials.gov study NCT03193788. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
ClinicalTrials.gov study NCT03150576. IPD Sharing: YES. Countries: 1. Publications: 3.
Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT00484666. IPD Sharing: Not stated. Countries: 1. Publications: 20.
Novara Registry of Platinum-Chromium Platform Stents
ClinicalTrials.gov study NCT01759719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
ClinicalTrials.gov study NCT06553157. IPD Sharing: NO. Countries: 1. Publications: 3.
Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma
ClinicalTrials.gov study NCT01828736. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase II Trial of HM781-36B in Patients With Metastatic/Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of or Unfit for Platinum-containing Therapy
ClinicalTrials.gov study NCT02216916. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants
ClinicalTrials.gov study NCT04893551. IPD Sharing: YES. Countries: 4. Publications: 1.
Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03170284. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
ClinicalTrials.gov study NCT06028932. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT02303977. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042
ClinicalTrials.gov study NCT02220894. IPD Sharing: YES. Countries: 0. Publications: 5.
A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer
ClinicalTrials.gov study NCT03695380. IPD Sharing: YES. Countries: 3. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.